GEPIA 2 analysis indicates insignificant increase of STC2 expression in breast cancer comparing with their normal counterparts, showing inconsistence with the published wet-bench studies, which directly compared the expression of STC2 proteins in this tumour [50, 51]. The gene discussed is STC2; the disease is breast carcinoma.